Analyst Ratings for Tenet Healthcare (THC)

THC Rating Summary

THC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on THC
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $276.74 (+4.1%) * Over Last 12-Mos
Rating Score: 7.4 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/14/2025 Goldman Sachs
» Updated 7/29/2026
Scott Fidel New Coverage Buy
(N/A)
305.00
(252.00)
189.58
(265.84)
40.23% Details
7/28/2025 Wolfe Research Justin Lake Downgrade Peerperform
(Outperform)
N/A
(N/A)
148.38
(265.84)
79.16% Details